フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Eli Lilly & Co on Tuesday said it expects to report lower fourth quarter revenue than the bottom of a range it had pr ...
...
Popular diabetes and obesity drugs by Novo Nordisk AS and Eli Lilly & Co could also help to protect the kidneys, a ne ...
Eli Lilly & Co on Wednesday reported strong revenue growth in the third quarter and a return to profit, as it develop ...
Eli Lilly & Co on Monday announced it has appointed Lucas Montarce as chief financial officer with immediate effect. ...
Eli Lilly & Co on Thursday raised annual guidance once again, as it reported double-digit growth in the second quarte ...
Patients taking Eli Lilly & Co's new drug Mounjaro achieved significantly greater weight loss than those on Novo Nord ...
Alphabet Inc on Wednesday said Anat Ashkenazi will become the company's new chief financial officer from the end of J ...
Eli Lilly & Co announced on Wednesday that it has come to an agreement with Totality Medispa over the latter's claim ...
Eli Lilly & Co on Tuesday lifted its full-year sales outlook as it reported increased demand for its weight-loss and ...
Eli Lilly & Co's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US phar ...
Eli Lilly & Co on Tuesday reported higher fourth-quarter sales, with sales of recently-launched weight loss drugs hel ...
A weight loss drug newly approved in a four-dose injection pen format by the Medicines & Healthcare products Regulato ...
- Indianapolis, Indiana-based pharmaceutical company - Subsidiary Akouos Inc reports positive initial clinical results ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約